Legal Issues

Court: Mycogen Corp. not entitled to damages regarding gene technology dispute

Published in Gene Therapy Weekly, September 19th, 2002

The California Supreme Court issued a ruling which ended efforts by Mycogen Corp. to recover $174.9 million awarded by a San Diego jury in a contract dispute with Monsanto Co. regarding plant gene technology.

Monsanto had performed its obligations to deliver genes due under the contract, but Mycogen had sought a double recovery of full future damages in addition to delivery of the valuable gene technology.

"We're delighted that the California Supreme Court has concluded that the jury award was improper and that this litigation is at an end," said Robert T. Fraley, PhD, chief technology officer for Monsanto. "We hope this sets the stage for us to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2002-09-19)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry